Compound ID | 304
LICA/WRAIR Project
Class: Membrane-active agent
| Agent Type: | Direct acting; |
| Spectrum of activity: | Gram-negative |
| Mechanism of action: | Membrane-active agent. Cell membrane modulators by interfering with fumarate reductase |
| Target Pathogen: | Active against Staphylococcus aureus |
| Description: | Also shows antimalarial activity |
| Institute where first reported: | LICA Pharmaceuticals, Denmark; Walter Reed Army Institute of Research, USA |
| Year first mentioned: | 1999 |
| Development status: | Experimental |
| External links: |
AntibioticDB is supported by GARDP.
If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions
The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.